Print Friendly, PDF & Email

NCT/Study#

NA /

2020-0081

Outcomes Of Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Patients: Real World Experience In Lymphoma Patients

DISEASE GROUP:

Lymphoma

current phase:

NA

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587